Cargando…
Refractory Choriocarcinoma: Complete Response With Oral Etoposide
Autores principales: | Dhanushkodi, Manikandan, Ganesan, Trivadi, Sagar, Tenali Gnana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646884/ https://www.ncbi.nlm.nih.gov/pubmed/29094106 http://dx.doi.org/10.1200/JGO.2016.006049 |
Ejemplares similares
-
Recurrent cervical cancer treated with palliative chemotherapy: real-world outcome
por: Mailankody, Sharada, et al.
Publicado: (2020) -
Pediatric Hodgkin Lymphoma Treated at Cancer Institute, Chennai, India: Long-Term Outcome
por: Radhakrishnan, Venkatraman, et al.
Publicado: (2016) -
Therapeutic Outcomes in High-Grade B-Cell Lymphoma, NOS: Retrospective Analysis
por: Karunakaran, Parathan, et al.
Publicado: (2022) -
Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report
por: Das, Sunil Kumar, et al.
Publicado: (2022) -
Can Radiotherapy Be Omitted in Children With Hodgkin Lymphoma Who
Achieve Metabolic Remission on Interim Positron Emission Tomography? Experience
of a Tertiary Care Cancer Referral Center
por: Totadri, Sidharth, et al.
Publicado: (2017)